Research ArticleBasic Science Investigations
Stratification of Nucleoside Analog Chemotherapy Using 1-(2′-Deoxy-2′-18F-Fluoro-β-d-Arabinofuranosyl)Cytosine and 1-(2′-Deoxy-2′-18F-Fluoro-β-l-Arabinofuranosyl)-5-Methylcytosine PET
Jason T. Lee, Dean O. Campbell, Nagichettiar Satyamurthy, Johannes Czernin and Caius G. Radu
Journal of Nuclear Medicine February 2012, 53 (2) 275-280; DOI: https://doi.org/10.2967/jnumed.111.090407
Jason T. Lee
Dean O. Campbell
Nagichettiar Satyamurthy
Johannes Czernin

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 53, Issue 2
February 1, 2012
Stratification of Nucleoside Analog Chemotherapy Using 1-(2′-Deoxy-2′-18F-Fluoro-β-d-Arabinofuranosyl)Cytosine and 1-(2′-Deoxy-2′-18F-Fluoro-β-l-Arabinofuranosyl)-5-Methylcytosine PET
Jason T. Lee, Dean O. Campbell, Nagichettiar Satyamurthy, Johannes Czernin, Caius G. Radu
Journal of Nuclear Medicine Feb 2012, 53 (2) 275-280; DOI: 10.2967/jnumed.111.090407
Stratification of Nucleoside Analog Chemotherapy Using 1-(2′-Deoxy-2′-18F-Fluoro-β-d-Arabinofuranosyl)Cytosine and 1-(2′-Deoxy-2′-18F-Fluoro-β-l-Arabinofuranosyl)-5-Methylcytosine PET
Jason T. Lee, Dean O. Campbell, Nagichettiar Satyamurthy, Johannes Czernin, Caius G. Radu
Journal of Nuclear Medicine Feb 2012, 53 (2) 275-280; DOI: 10.2967/jnumed.111.090407
Jump to section
Related Articles
Cited By...
- Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer
- STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [18F]FLT PET imaging
- Defective Nucleotide Catabolism Defines a Subset of Cancers Sensitive to Purine Nucleoside Phosphorylase Inhibition
- [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity
- Evaluation of the Genisys4, a Bench-Top Preclinical PET Scanner
- Metabolomics Strategy Reveals Subpopulation of Liposarcomas Sensitive to Gemcitabine Treatment